| Literature DB >> 27995384 |
Ugo Fiocco1, Roberto Stramare2, Veronica Martini3, Alessandro Coran2, Francesco Caso4, Luisa Costa4, Mara Felicetti5, Gaia Rizzo6, Matteo Tonietto6, Anna Scanu5, Francesca Oliviero5, Bernd Raffeiner5, Maristella Vezzù5, Francesca Lunardi7, Raffaele Scarpa4, David Sacerdoti8, Leopoldo Rubaltelli2, Leonardo Punzi5, Andrea Doria5, Enrico Grisan6.
Abstract
To develop quantitative imaging biomarkers of synovial tissue perfusion by pixel-based contrast-enhanced ultrasound (CEUS), we studied the relationship between CEUS synovial vascular perfusion and the frequencies of pathogenic T helper (Th)-17 cells in psoriatic arthritis (PsA) joints. Eight consecutive patients with PsA were enrolled in this study. Gray scale CEUS evaluation was performed on the same joint immediately after joint aspiration, by automatic assessment perfusion data, using a new quantification approach of pixel-based analysis and the gamma-variate model. The set of perfusional parameters considered by the time intensity curve includes the maximum value (peak) of the signal intensity curve, the blood volume index or area under the curve, (BVI, AUC) and the contrast mean transit time (MTT). The direct ex vivo analysis of the frequencies of SF IL17A-F+CD161+IL23+ CD4+ T cells subsets were quantified by fluorescence-activated cell sorter (FACS). In cross-sectional analyses, when tested for multiple comparison setting, a false discovery rate at 10%, a common pattern of correlations between CEUS Peak, AUC (BVI) and MTT parameters with the IL17A-F+IL23+ - IL17A-F+CD161+ - and IL17A-F+CD161+IL23+ CD4+ T cells subsets, as well as lack of correlation between both peak and AUC values and both CD4+T and CD4+IL23+ T cells, was observed. The pixel-based CEUS assessment is a truly measure synovial inflammation, as a useful tool to develop quantitative imaging biomarker for monitoring target therapeutics in PsA.Entities:
Keywords: Imaging ultrasound; Interleukin-17; Psoriatic arthritis; Quantitative imaging; T cells
Mesh:
Substances:
Year: 2016 PMID: 27995384 DOI: 10.1007/s10067-016-3500-x
Source DB: PubMed Journal: Clin Rheumatol ISSN: 0770-3198 Impact factor: 2.980